Robin Ali is Professor of Human Molecular Genetics at King’s College London and Director of The KCL Centre for Cell and Gene Therapy. He is also Deputy Director, NIHR Guy’s and St Thomas’ Biomedical Research Centre and Director of the KCL/BRC Advanced Therapies Accelerator.
He is also Visiting Professor at Kellogg Eye Center, University of Michigan and Founder of MeiraGTx PLC, a Nasdaq-listed gene therapy company with offices in London and New York.